579-Oncolytic Virus Triggers Persistent T Cell Immunity

This research article investigates how a single oncolytic virus treatment can trigger a robust and lasting immune response in patients with recurrent glioblastoma. Using advanced spatial technologies like CODEX and Xenium, the authors demonstrate that the therapy causes T cells to infiltrate deeply into tumor regions, where they remain active for months or even years. The study highlights that the...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动